Insider · CIK 0001762163
Jeffrey S Ervin
Files at ALLR (Allarity Therapeutics, Inc.), CING (Cingulate Inc.). First filing -, latest -.
In brief
Jeffrey S Ervin files SEC Form 4 as director and CFO at ALLR (Allarity Therapeutics, Inc.), and also at CING (Cingulate Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jeffrey S Ervin has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 28, 2026 | ALLR Allarity Therapeutics, Inc. | AGrant or award Common Stock | +150,000 | $0.00 | $0 | 150,000 | Apr 30, 2026 |
| Jun 20, 2025 | CING Cingulate Inc. | AGrant or award Stock Option (right to Buy)derivative | +15,000 | $0.00 | $0 | 15,000 | Jun 23, 2025 |
Questions about Jeffrey S Ervin
Answered from the filings on this page, as of the latest one.
Is Jeffrey S Ervin buying or selling?
Jeffrey S Ervin has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jeffrey S Ervin's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jeffrey S Ervin has 0.
Where does Jeffrey S Ervin file Form 4?
Jeffrey S Ervin has filed Form 4 at ALLR (Allarity Therapeutics, Inc.) as CFO; CING (Cingulate Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.